The Usefulness of 18F-FDG PET to Differentiate Subtypes of Dementia: The Systematic Review and Meta-Analysis

키워드

참고문헌 (44)

1. "2023 Alzheimer’s disease facts and figures", Alzheimers Dement, 19, pp.1598~1695 (2023)
2. Pink J, "Dementia: assessment, management and support: summary of updated NICE guidance", BMJ, 361, pp.k2438~ (2018)
3. Filippi M, "EFNS task force : the use of neuroimaging in the diagnosis of dementia", Eur J Neurol, 19, pp.1487~1501 (2012)
4. Arvanitakis Z, "Diagnosis and management of dementia", JAMA, 322, pp.1589~1599 (2019)
5. Jack CR Jr, "NIA-AA Research Framework : toward a biological definition of Alzheimer’s disease", Alzheimers Dement, 14, pp.535~562 (2018)
6. Gorno-Tempini ML, "Classification of primary progressive aphasia and its variants", Neurology, 76, pp.1006~1014 (2011)
7. Rascovsky K, "Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia", Brain, 134, pp.2456~2477 (2011)
8. FDG PET for clinical dementia workup : differential diagnosis of Alzheimer’s disease and other types of dementing disorders, "Semin Nucl Med", 2021, 230~240
9. Sarikaya I, "Current status of 18F-FDG PET brain imaging in patients with dementia", J Nucl Med Technol, 46, pp.362~367 (2018)
10. Lee JS, "Clinical Practice Guideline for Dementia(Diagnosis and Evaluation) : 2021 Revised Edition", Dement Neurocogn Disord, 21, pp.42~44 (2022)
11. Whiting PF, "QUADAS-2 : a revised tool for the quality assessment of diagnostic accuracy studies", Ann Intern Med, 155, pp.529~536 (2011)
12. Dukart J, "Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia", PLoS One, 6, pp.e18111~ (2011)
13. Foster NL, "FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease", Brain, 130, pp.2616~2635 (2007)
14. Mosconi L, "Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias", J Nucl Med, 49, pp.390~398 (2008)
15. FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration, "Eur Arch Psychiatry Clin Neurosci", 2011, 433~446
16. Rabinovici GD, "Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD", Neurology, 77, pp.2034~2042 (2011)
17. Lim SM, "The 18F-FDG PET cingulate island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies", J Nucl Med, 50, pp.1638~1645 (2009)
18. O’Brien JT, "18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias", J Nucl Med, 55, pp.1959~1965 (2014)
19. -FDG pet study, "J Neuroimaging", 2015, 281~288
20. Jagust W, "What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?", Neurology, 69, pp.871~877 (2007)
21. Perini G, "Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis", Eur J Nucl Med Mol Imaging, 48, pp.612~622 (2021)
22. Tripathi M, "Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET", CT, 2014, pp.27, 13~21
23. Panegyres PK, "Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia : a prospective, community-based study", BMC Neurol, 9, pp.41~ (2009)
24. Taswell C, "18F-FDG PET improves diagnosis in patients with focal-onset dementias", J Nucl Med, 56, pp.1547~1553 (2015)
25. FDG-PET for behavioral variant frontotemporal dementia in patients with late onset behavioral changes, "J Alzheimers Dis", 2016, 1287~1297
26. "Dementia: assessment, management and support for people living with dementia and their carers" (2018)[URL]
27. Ismail Z, "Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia", Alzheimers Dement, 16, pp.1182~1195 (2020)
28. Knopman DS, "Practice parameter : diagnosis of dementia(an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology", Neurology, 56, pp.1143~1153 (2001)
29. Burdette JH, "Alzheimer disease : improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections", Radiology, 198, pp.837~843 (1996)
30. Minoshima S, "18F-FDG PET imaging in neurodegenerative dementing disorders : insights into subtype classification, emerging disease categories, and mixed dementia with copathologies", J Nucl Med, 63, pp.2S~12S (2022)
31. Chételat G, "Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias", Lancet Neurol, 19, pp.951~962 (2020)
32. Hampel H, "Developing the ATX(N)classification for use across the Alzheimer disease continuum", Nat Rev Neurol, 17, pp.580~589 (2021)
33. Kim EJ, "Glucose metabolism in early onset versus late onset Alzheimer’s disease : an SPM analysis of 120 patients", Brain, 128, pp.1790~1801 (2005)
34. Graff-Radford J, "Dementia with Lewy bodies : basis of cingulate island sign", Neurology, 83, pp.801~809 (2014)
35. McKeith IG, "Diagnosis and management of dementia with Lewy bodies : fourth consensus report of the DLB Consortium", Neurology, 89, pp.88~100 (2017)
36. Liang CS, "Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias : a systematic review and meta-analysis", Lancet Healthy Longev, 2, pp.e479~e488 (2021)
37. Mendez MF, "Preliminary findings : behavioral worsening on donepezil in patients with frontotemporal dementia", Am J Geriatr Psychiatry, 15, pp.84~87 (2007)
38. Johnson KA, "Appropriate use criteria for amyloid PET : a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association", Alzheimers Dement, 9, pp.e-1~e-16 (2013)
39. Clark CM, "Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques : a prospective cohort study", Lancet Neurol, 11, pp.669~678 (2012)
40. Jansen WJ, "Prevalence of cerebral amyloid pathology in persons without dementia : a meta-analysis", JAMA, 313, pp.1924~1938 (2015)
41. Rahimi J, "Prevalence of mixed pathologies in the aging brain", Alzheimers Res Ther, 6, pp.82~ (2014)
42. Chong A, "Recent survey of effective doses of F-18 FDG torso PET", CT in Korea and the current recommendations for CT protocols of PET, Nucl Med Mol Imaging, pp.2020, 54[DOI]
43. "AAPM position statement on radiation risks from medical imaging procedures, November 16, 2023. Board of Directors Meeting" (2023)[URL]
44. NECA Round Table Conference for Social Consensus, "Choi JE", National Evidence-based Healthcare Collaborating Agency, 56~75 (2014)

관련 논문AI추천